Berenberg downgrades AG Barr as weak volumes cloud growth outlook

Berenberg downgraded AG Barr to hold from buy and cut its price target to 625p from 800p after first-half like-for-like volumes fell 2%-3% and IRN-BRU sales were flat. A second-quarter supply-chain disruption cut sales by about £10m, or roughly 400bps, while free cash flow shifted to a £28.8m outflow and net debt rose about £30m to £47m. Although first-half revenue increased 8.5% to £247.4m and management maintained FY2027 targets, Berenberg sees limited near-term catalysts and a less certain growth outlook.

Analysis

BAG’s investment case is shifting from a dependable premium-growth compounder toward an execution-dependent recovery story. The key concern is not the isolated operational disruption but the weak underlying volume response after pricing: if price/mix is carrying growth while unit demand remains muted, the company has limited room to protect its 15% margin should input-cost inflation reaccelerate or promotional intensity rise. With IRN-BRU representing a concentrated profit pool, sustained brand-volume stagnation would make the current return-on-capital target increasingly reliant on cost actions rather than organic operating leverage.

The balance-sheet and cash-conversion profile merit more attention than headline operating profit. A second-half working-capital release can mechanically repair reported free cash flow, but investors should distinguish this from recurring cash generation while capex remains elevated and leverage has risen. Over the next 1-3 months, evidence that distribution/service levels have normalized and volumes have moved above low-single-digit growth is needed to prevent further multiple de-rating; over 6-18 months, the downside case is a lower terminal growth assumption rather than a major earnings collapse.

Consensus may be too quick to treat the disruption as wholly transitory, but the opposite contrarian case is also plausible: BAG is now at the bottom of its annual trading range despite an apparently resolvable supply issue and management retaining full-year objectives. The stock becomes interesting only if subsequent trading shows volume recovery without incremental discounting. Until then, the asymmetry favors waiting rather than treating the reduced broker target as a standalone catalyst.

Key Decisions for Investors

• Maintain or initiate a tactical underweight/short BAG for the next 1-3 months versus long CCH.L as a UK beverage defensiveness pair; BAG has greater exposure to domestic volume elasticity and execution risk, while CCH.L offers geographic diversification. Cover if BAG demonstrates underlying volume growth above 3% for two consecutive reporting periods or restores cash conversion without further debt build.
• Do not buy the post-results weakness solely on the expectation of a second-half working-capital unwind. Set an alert for evidence that net debt declines materially from current levels by fiscal year-end and that operating margin remains at or above 15%; absent both, a recovery in reported free cash flow is not sufficient confirmation.
• For long-only accounts, defer new BAG exposure until the next trading update verifies normalized supply availability and positive volumes excluding price/mix. A position initiated after this confirmation has a clearer path to re-rating; failure to deliver would imply the company’s stated revenue target is vulnerable and warrants avoiding the name.
• Monitor UK policy developments around the Soft Drinks Industry Levy as a 6-18 month optionality/risk factor. A harsher levy regime would pressure category pricing and mix; a favorable outcome could support a selective BAG long, but this is a watch item rather than a current trade catalyst.